Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Miles P Sparrow

Showing results (91-100 of 100) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 100 results.
BMJ Open Gastroenterology|February 20, 2026
Evaluating treatment to a target of transmural healing in patients with moderately to severely active Crohn's disease: rationale, design and protocol for the randomised controlled VECTORS trialVipul Jairath, Sudheer K Vuyyuru, Guangyong Zou, et al.
Journal of Gastroenterology and Hepatology|December 16, 2016
Serologic antibodies in relation to outcome in postoperative Crohn's diseaseAmy L Hamilton, Michael A Kamm, Peter De Cruz, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 14, 2021
Higher Anti-tumor Necrosis Factor-α Levels Correlate With Improved Radiologic Outcomes in Crohn's Perianal FistulasMichael De Gregorio, Tanya Lee, Krupa Krishnaprasad, et al.
Inflammatory Bowel Diseases|December 3, 2025
Low Rates of Surgical Recurrence Following Ileocolic Resections for Crohn's Disease in the Biologic EraHugh L Giddings, Kheng-Seong Ng, Michael J Solomon, et al.
The Lancet. Gastroenterology & Hepatology|September 5, 2024
Intensified versus standard dose infliximab induction therapy for steroid-refractory acute severe ulcerative colitis (PREDICT-UC): an open-label, multicentre, randomised controlled trialMatthew C Choy, Christopher F D Li Wai Suen, Danny Con, et al.
JGH Open : an Open Access Journal of Gastroenterology and Hepatology|December 12, 2025
Australian Real-World Effectiveness and Safety of Ustekinumab for the Treatment of Crohn's Disease: Results of the AURORA Study, Including the ANZIBD ConsortiumYoon-Kyo An, Niamh Lindsay, Natalie Allan, et al.
Inflammatory Bowel Diseases|May 30, 2019
Anti-TNF Therapy in Pregnant Women With Inflammatory Bowel Disease: Effects of Therapeutic Strategies on Disease Behavior and Birth OutcomesMette Julsgaard, Christian L Hvas, Richard B Gearry, et al.
Journal of Crohn'S & Colitis|March 11, 2025
Definitions, diagnosis, and management of postoperative recurrence in Crohn's disease patients with permanent ileostomy-a systematic review and meta-analysisSuha Abushamma, Tesfaye Yadete, Neil Nero, et al.
Journal of Crohn'S & Colitis|April 10, 2015
Effect of intestinal resection on quality of life in Crohn's diseaseEmily K Wright, Michael A Kamm, Peter De Cruz, et al.
Gastroenterology|July 23, 2025
Early Infliximab Levels and Clearance Predict Outcomes After Infliximab Rescue in Acute Severe Ulcerative Colitis: Results From PREDICT-UCChristopher F D Li Wai Suen, Matthew C Choy, Danny Con, et al.
Pageof 10

Showing results (91-100 of 100) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 100 results.
BMJ Open Gastroenterology|February 20, 2026
Evaluating treatment to a target of transmural healing in patients with moderately to severely active Crohn's disease: rationale, design and protocol for the randomised controlled VECTORS trialVipul Jairath, Sudheer K Vuyyuru, Guangyong Zou, et al.
Journal of Gastroenterology and Hepatology|December 16, 2016
Serologic antibodies in relation to outcome in postoperative Crohn's diseaseAmy L Hamilton, Michael A Kamm, Peter De Cruz, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 14, 2021
Higher Anti-tumor Necrosis Factor-α Levels Correlate With Improved Radiologic Outcomes in Crohn's Perianal FistulasMichael De Gregorio, Tanya Lee, Krupa Krishnaprasad, et al.
Inflammatory Bowel Diseases|December 3, 2025
Low Rates of Surgical Recurrence Following Ileocolic Resections for Crohn's Disease in the Biologic EraHugh L Giddings, Kheng-Seong Ng, Michael J Solomon, et al.
The Lancet. Gastroenterology & Hepatology|September 5, 2024
Intensified versus standard dose infliximab induction therapy for steroid-refractory acute severe ulcerative colitis (PREDICT-UC): an open-label, multicentre, randomised controlled trialMatthew C Choy, Christopher F D Li Wai Suen, Danny Con, et al.
JGH Open : an Open Access Journal of Gastroenterology and Hepatology|December 12, 2025
Australian Real-World Effectiveness and Safety of Ustekinumab for the Treatment of Crohn's Disease: Results of the AURORA Study, Including the ANZIBD ConsortiumYoon-Kyo An, Niamh Lindsay, Natalie Allan, et al.
Inflammatory Bowel Diseases|May 30, 2019
Anti-TNF Therapy in Pregnant Women With Inflammatory Bowel Disease: Effects of Therapeutic Strategies on Disease Behavior and Birth OutcomesMette Julsgaard, Christian L Hvas, Richard B Gearry, et al.
Journal of Crohn'S & Colitis|March 11, 2025
Definitions, diagnosis, and management of postoperative recurrence in Crohn's disease patients with permanent ileostomy-a systematic review and meta-analysisSuha Abushamma, Tesfaye Yadete, Neil Nero, et al.
Journal of Crohn'S & Colitis|April 10, 2015
Effect of intestinal resection on quality of life in Crohn's diseaseEmily K Wright, Michael A Kamm, Peter De Cruz, et al.
Gastroenterology|July 23, 2025
Early Infliximab Levels and Clearance Predict Outcomes After Infliximab Rescue in Acute Severe Ulcerative Colitis: Results From PREDICT-UCChristopher F D Li Wai Suen, Matthew C Choy, Danny Con, et al.
Pageof 10